Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-07-31 2020-07-31
Drug Identification Number 02241112 02241112
Brand name AVANDIA AVANDIA
Common or Proper name rosiglitazone (as rosiglitazone maleate) tablets rosiglitazone (as rosiglitazone maleate) tablets
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients ROSIGLITAZONE ROSIGLITAZONE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60's 60's
ATC code A10BG A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-08-31 2020-08-31
Actual discontinuation date
Remaining supply date 2021-09-30 2021-09-30
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments